Medeva shares dive on obesity drug fears

Health fears over Medeva's new anti-obesity drug, Ionamin, coupled with a warning about full-year profits, drove the share price in the UK's fourth biggest drug group down by 13 per cent to 222p yesterday.

Dr Bill Bogie, chief executive, said sales of Ionamin had collapsed to pounds 7m in the first six months of this year from pounds 21m in the second half of 1996, and would be unlikely to recover in the short term after a warning from the US drug regulator last week linking anti-obesity pills with heart failure.

Analysts were surprised by the news on Ionamin and cut full-year forecasts for group profits from pounds 120m-pounds 132m to pounds 110m-pounds 115m.

First-half sales of Ionamin, which was bought from Rhone Poulenc last year and has been sold in the US since 1959, were affected by destocking and competition.

James Culverwell, an analyst at Merrill Lynch, said: "Medeva had always said that Ionamin would be a wild card, but no one thought it would be this bad." Analysts were also concerned about Ionamin's prospects, given that Roche's Xenical anti-fat pill, a safer breed of drug, could be launched shortly.

However, Dr Bogie said he still expected growth from Ionamin. "It's not like we've bought a dead duck. The obesity market is growing."

He warned that second half profits also depended on emerging competition for Methylphenidate, the group's leading drug for hyperactivity, which grew sales by 6 per cent to pounds 54m in the half year

Medeva has more than 70 per cent of the US market for this quota-controlled and licensed drug. However, three other generic companies, Johnson Matthey, Mallinckrodt and Ganes, have obtained licences. The first new generic drug is expected to enter the market by Christmas. Dr Bogie said although sales were likely to slip by around 15 per cent next year, the quota system would prevent a rush of lower-priced generics into the market.

Dr Bogie was upbeat over other products. "People should see that we are following our strategy. I am not worried about our share price. Glaxo made a remarkable turnaround after fears over Zantac."

However analysts were sceptical. Kevin Scotcher at NatWest said: "The great hope of replacing Methylphenidate with Ionamin has gone. And whether Medeva had good follow-up drugs is unclear."

Investment column, page 24

Suggested Topics
PROMOTED VIDEO
News
Bryan Cranston as Walter White, in the acclaimed series 'Breaking Bad'
news
News
Those who were encouraged to walk in a happy manner remembered less negative words
science
Sport
footballChelsea 6 Maribor 0: Blues warm up for Premier League showdown with stroll in Champions League
Arts and Entertainment
Princess Olga in 'You Can't Get the Staff'
tvReview: The anachronistic aristocrats, it seemed, were just happy to have some attention
News
Renee Zellweger as Bridget Jones
i100
Life and Style
tech

Board creates magnetic field to achieve lift

News
ebooksAn unforgettable anthology of contemporary reportage
News
There have been various incidents of social media users inadvertently flouting the law
news

Life and Style
Stack ‘em high?: quantity doesn’t always trump quality, as Friends of the Earth can testify
techThe proliferation of online petitions allows us to register our protests at the touch of a button. But do they change anything?
News
Bourgogne wine maker Laboure-Roi vice president Thibault Garin (L) offers the company's 2013 Beaujolais Nouveau wine to the guest in the wine spa at the Hakone Yunessun spa resort facilities in Hakone town, Kanagawa prefecture, some 100-kilometre west of Tokyo
i100
Sport
CSKA Moscow celebrate after equalising with a late penalty
footballCSKA Moscow 2 Manchester City 2: Premier League champions let two goal lead slip in Russia
Environment
Sudan, the last male northern white rhino
environmentThe death of a white northern rhino in Kenya has left the species with a single male. These are the other species on the brink
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Helpdesk Analyst

£23000 per annum + pension and 22 days holiday: Ashdown Group: An established ...

Senior Helpdesk Analyst / Service Desk Co-ordinator

£27000 per annum + pension, 22 days holiday: Ashdown Group: An established ind...

Senior Pensions Administrator

£23000 - £26000 Per Annum: Clearwater People Solutions Ltd: Our client is curr...

Corporate Actions Administrator / Operations Administrator

£25 - 30k: Guru Careers: A Corporate Actions Administrator / Operations Admini...

Day In a Page

Indiana serial killer? Man arrested for murdering teenage prostitute confesses to six other murders - and police fear there could be many more

A new American serial killer?

Police fear man arrested for murder of teen prostitute could be responsible for killing spree dating back 20 years
Sweetie, the fake 10-year-old girl designed to catch online predators, claims her first scalp

Sting to trap paedophiles may not carry weight in UK courts

Computer image of ‘Sweetie’ represented entrapment, experts say
Fukushima nuclear crisis: Evacuees still stuck in cramped emergency housing three years on - and may never return home

Return to Fukushima – a land they will never call home again

Evacuees still stuck in cramped emergency housing three years on from nuclear disaster
Online petitions: Sign here to change the world

Want to change the world? Just sign here

The proliferation of online petitions allows us to register our protests at the touch of a button. But do they change anything?
Ed Sheeran hits back after being labelled too boring to headline festivals

'You need me, I don’t need you'

Ed Sheeran hits back after being labelled too boring to headline festivals
How to Get Away with Murder: Shonda Rhimes reinvents the legal drama

How to Get Away with Murder

Shonda Rhimes reinvents the legal drama
A cup of tea is every worker's right

Hard to swallow

Three hospitals in Leicester have banned their staff from drinking tea and coffee in public areas. Christopher Hirst explains why he thinks that a cuppa is every worker's right
Which animals are nearly extinct?

Which animals are nearly extinct?

Conservationists in Kenya are in mourning after the death of a white northern rhino, which has left the species with a single male. These are the other species on the brink
12 best children's shoes

Perfect for leaf-kicking: 12 best children's shoes

Find footwear perfect to keep kids' feet protected this autumn
Anderlecht vs Arsenal: Gunners' ray of light Aaron Ramsey shines again

Arsenal’s ray of light ready to shine again

Aaron Ramsey’s injury record has prompted a club investigation. For now, the midfielder is just happy to be fit to face Anderlecht in the Champions League
Comment: David Moyes' show of sensitivity thrown back in his face by former Manchester United manager Sir Alex Ferguson

Moyes’ show of sensitivity thrown back in his face... by Ferguson

Manchester United legend tramples on successor who resisted criticising his inheritance
Two super-sized ships have cruised into British waters, but how big can these behemoths get?

Super-sized ships: How big can they get?

Two of the largest vessels in the world cruised into UK waters last week
British doctors on brink of 'cure' for paralysis with spinal cord treatment

British doctors on brink of cure for paralysis

Sufferers can now be offered the possibility of cure thanks to a revolutionary implant of regenerative cells
Let's talk about loss

We need to talk about loss

Secrecy and silence surround stillbirth